Agile Therapeutics News

8-K: Current report

May 21 08:35 ET

8-K: AGILE THERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 15 16:24 ET

Agile Therapeutics | 8-K: Current report

Apr 9 08:34 ET

Agile Therapeutics | 8-K: AGILE THERAPEUTICS REPORTS FOURTH QUARTER & FULL YEAR 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Mar 28 09:09 ET

Agile Therapeutics | 8-K: Current report

Mar 25 16:35 ET

Agile Therapeutics | 8-K: Current report

Mar 14 16:50 ET

Agile Therapeutics | 8-K: Current report

Feb 23 22:23 ET

Agile Therapeutics | 8-K: Current report

Feb 15 16:48 ET

Agile Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 7 16:57 ET

Agile Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 5 09:23 ET

Agile Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Feb 2 16:34 ET

Agile Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Dec 20, 2023 08:00 ET

Agile Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Dec 11, 2023 17:30 ET

Agile Therapeutics | 8-K: Current report

Dec 6, 2023 08:00 ET

Agile Therapeutics | 8-K: Current report

Dec 4, 2023 08:00 ET

Agile Therapeutics | 8-K: AGILE THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Nov 9, 2023 08:15 ET

Agile Therapeutics | 8-K: Current report

Oct 2, 2023 16:30 ET

Agile Therapeutics | 8-K: Current report

Sep 28, 2023 16:50 ET

Agile Therapeutics | 8-K/A: Current report (Amendment)

Aug 22, 2023 08:30 ET

Agile Therapeutics | 8-K: AGILE THERAPEUTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

Aug 9, 2023 08:10 ET